Skip to main content

Prototype bird flu vax by April

NIBSC says a deletion H5N1 virus for vaccine will be ready for manufacturers in a month

Written byRobert Walgate
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

A deletion virus vaccine for H5N1 avian flu, created by reverse genetics, will be ready to go to “any manufacturer that wants it” by mid-April, John Wood of the UK's National Institute for Biological Standards and Control (NIBSC) has told The Scientist.

H5N1 has attacked eight Asian countries and killed 100 million birds, and is “historically unprecedented” as an epidemic of this kind, Anarfi Asamoa-Baah, World Health Organization (WHO) Assistant Director-General for Communicable Diseases, said on Tuesday (March 16).

According to WHO figures, by March 10 there had been 22 confirmed deaths in humans, all in Thailand and Vietnam, but the organization continues to fear the virus may mutate into a more virulent form.

Addressing a conference in Geneva on preparedness for the next influenza pandemic, Asamoa-Baah warned that WHO was already aware of reports “that H5N1 is causing disease and death in an unusual range of mammalian species.”

“Of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo